INTRODUCTION
The classification of canine lymphoid malignancies into groups based on cell of origin (B-or T-cell types) is possible with immunophenotypic analysis. A high frequency of B-cell lymphomas has been described; about 30% of lymphomas are of T-cell origin (Teske et al., 1994a; Fournel-Fleury et al., 1997; Grindem et al., 1998) . In human medicine the major diagnostic role of blood lymphocyte subset typing is the screening for non-Hodgkin's lymphomas with peripheral blood involvement and their differentation from reactive lymphoproliferative conditions (Thalhammer-Scherrer et al., 2000) . The aim of this project is to evaluate the diagnostic efficacy of blood immunophenotyping in dogs with lymphoma in order to detect the blood involvement and the prognostic benefits.
MATERIALS AND METHODS
Forty-eight dogs, 32 males and 16 females, ranging from 3 to 14 years old, of varying breeds, were examined. The diagnosis of lymphoma was performed on cytological smears. The immunophenotype was detected from lymph node cellular suspensions or cavity fluids using flow cytometry (FACScan Becton Dickinson): 36 cases were CD21+ B-cell, 7 were CD4+ T-cell, 3 were CD8+ T-cell and 2 were CD4−CD8− T-cell lymphomas. A complete blood count and a phenotypic analysis of blood lymphocyte subpopulations were performed. The following monoclonal antibodies, specific for canine leukocyte antigens, were used: CD21 (CA2.1D6), IgG F(ab∞) 2 and IgM, CD5 (DH3B), CD3 (CA17.2A12), CD4 (CA13.1E4), CD8 (CA9.JD3), CD45RA (CA4.1D3), CD49d (CA4.5B3) and CD45 (CA12.10C12). Except for CD5 (VMRD, Pulmann, Washington, USA) and IgG, IgM (Jackson Immunoresearch, West Grove, PA, USA), all monoclonal antibodies were kindly provided by Dr P.F. Moore (U.C.
Davies, CA, USA). The results were compared to reference values of a control goup of 50 healthy dogs (Guglielmino et al., 1995) .
RESULTS
In agreement with Jain (1993) , the complete blood count showed a mild to modest anaemia in 46% of the dogs, thrombocytopenia in 44% and mild (18,300/ml) to extreme (342,000/ml) leukocytosis in 33%. Only 19% of cases exhibited lymphocytosis; lymphoblasts were present for 12 dogs (25%), and 15% were without lymphocytosis. In 10% of cases leukopenia was observed and lymphopenia was observed in 25% of cases. Five out of 36 (14%) B-cell lymphomas showed CD21+ B-cell lymphocytosis (ranging from 5520 to 115,670/ml); four cases showed a moderate increase of B lymphocytes without lymphocytosis. A CD8+ T-cell increase was observed in seven B-cell lymphomas. This is also noted for human patients with neoplastic disorders, where an increase in the so-called 'anti-tumour' cytolytic CD8+ T lymphocytes occurs (Quaglino et al., 1993) . Two out of seven CD4+ T-cell lymphomas showed lymphocytosis (17,680 and 45,050/ml) with an increase in CD4+ T lymphocytes. Five dogs (71%) exhibited an increased CD4/CD8 ratio: in three cases this was due to an absolute increase in CD4+ T cells. One dog showed an abnormal immunophenotype (TCD4+CD45−) both in the lymph node and in the peripheral blood. In two out of the three dogs with CD8+ T-cell lymphoma a mild increase in the absolute count of CD8+ T lymphocytes, without lymphocytosis, was noted; one of these showed the same abnormal immunophenotype as the lymph node (TCD8+CD45−). Extreme lymphocytosis (12,690 and 338,580/ml), due to neoplastic cells, was observed for two dogs with CD4−CD8− T-cell lymphoma.
DISCUSSION
In dogs with lymphoma the total and differential leukocyte counts and the presence of atypical lymphocytes were very variable: indeed blood involvement was not always detectable on a simple complete blood count. The detection of neoplastic cells (5 T-cell and 4 B-cell lymphomas) with the same immunophenotype as the origin tumours, also without lymphocytosis and cells with atypical morphology, was possible using flow cytometric analysis of peripheral blood. The immunophenotype of the peripheral blood was able to provide more precise information about systemic involvement. In 75% (9/12) of T-cell lymphomas and in 25% (9/36) of B-cell lymphomas a systemic involvement was present, confirming a poorer prognosis for T-cell lymphomas as compared with B-cell lymphomas (Teske et al., 1994b) . Simultaneous immunophenotyping of blood, lymph node and bone marrow from dogs with lymphoma could represent an important diagnostic and prognostic tool. Our study supports the potential use of blood immunophenotyping as a sensitive tool in the
